Hala Abisamra
Cardiovascular Disease · Charleston, SCNPI 1164984738
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,795 of the $6,387 with a category attached, or 75.1%. 31 manufacturers reported payments, led by Medtronic at 34.4% of the total. Reporting peaked in 2022 at $3,300 and has fallen 87.2% since, to $422 in 2025.
Across 156 payments — averaging $40.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Abiomed$1K
- AstraZeneca$474
- Boehringer Ingelheim$307
- Irhythm Technologies, Inc.$250
- Pfizer$195
- plus $2K from 25 others
What the payments were for
- Travel & lodging$1,59225%
- Food & beverage$4,79575%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 19 | $2,195 |
| Abiomed | 21 | $1,166 |
| AstraZeneca | 12 | $474 |
| Boehringer Ingelheim | 9 | $307 |
| Irhythm Technologies, Inc. | 10 | $250 |
| Pfizer | 12 | $195 |
| Johnson & Johnson(2 entities) | 9 | $183 |
| Boston Scientific | 5 | $182 |
| Novartis | 9 | $168 |
| E.r. Squibb & Sons, L.L.C. | 8 | $134 |
| Bayer | 4 | $128 |
| Amgen | 3 | $123 |
| Impulse Dynamics (USA) Inc. | 5 | $104 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $92 |
| Shockwave Medical, Inc | 1 | $92 |
| Inspire Medical Systems, Inc. | 4 | $87 |
| Abbott | 3 | $72 |
| AbbVie | 3 | $67 |
| Actelion Pharmaceuticals US, Inc. | 2 | $64 |
| Merck | 3 | $48 |
| Angiodynamics, Inc. | 1 | $41 |
| Livanova USA, Inc. | 2 | $40 |
| Procyrion, Inc. | 1 | $34 |
| Novo Nordisk | 2 | $28 |
| Philips North America LLC | 1 | $25 |
| Gilead | 1 | $20 |
| United Therapeutics Corporation | 1 | $16 |
| Edwards Lifesciences | 1 | $14 |
| Alnylam Pharmaceuticals Inc. | 1 | $14 |
| Scpharmaceuticals Inc. | 1 | $13 |
| Biotronik Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$626
- JARDIANCE$125
- BRILINTA$124
- WATCHMAN Access System$113
How this compares
$6,387 in reported general payments places this provider in the 65th percentile of 257 cardiovascular disease providers in South Carolina.
See all cardiovascular disease providers in South Carolina →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 15 | $152 |
| Levetiracetam | 11 | $105 |
| ClopidogrelClopidogrel Bisulfate | 18 | $79 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 17 | $47 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Charleston
- Robert BiedermanCharleston$775K
- Priyanka BhattacharyaCharleston$107K
- James SmithCharleston$64K
- Geetha PintoCharleston$51K
- Pamela MorrisCharleston$23K
- Ian LaxinaCharleston$21K
- William YarbroughCharleston$19K
- Minh TranCharleston$18K
- Troy BuntingCharleston$16K
- Samuel PowellCharleston$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.